{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:23:40Z","timestamp":1778678620217,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior (CAPES)"},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)"},{"name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Goi\u00e1s (FAPEG)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.peptides.2018.10.005","type":"journal-article","created":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T09:19:59Z","timestamp":1540113599000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["BJ-PRO-7A and BJ-PRO-10C induce vasodilatation and inotropic effects in normotensive and hypertensive rats: Role of nitric oxide and muscarinic receptors"],"prefix":"10.1016","volume":"110","author":[{"given":"A.D.C.","family":"Nunes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.H.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.P.","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ianzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9510-1124","authenticated-orcid":false,"given":"C.H.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2018.10.005_bib0005","series-title":"WHO, Cardiovascular Diseases (CVDs)","author":"W.H.O","year":"2013"},{"key":"10.1016\/j.peptides.2018.10.005_bib0010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/1470320312443910","article-title":"The role of angiotensin receptor blockers in reducing the risk of cardiovascular disease","volume":"13","author":"Abramov","year":"2012","journal-title":"J. Renin. Angiotensin. Aldosterone. Syst."},{"key":"10.1016\/j.peptides.2018.10.005_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.HYP.0000252676.46043.18","article-title":"Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004","volume":"49","author":"Ong","year":"2007","journal-title":"Hypertension"},{"issue":"252","key":"10.1016\/j.peptides.2018.10.005_bib0020","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1126\/science.2063193","article-title":"Blood pressure control special role of the kidneys and body fluids","volume":"80","author":"Guyton","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.peptides.2018.10.005_bib0025","first-page":"276","article-title":"Potencia\u00e7\u00e3o de polipept\u00eddeos (Bradicinina, Angiotensina, Ocitocina, etc.) por um fator presente no veneno da B. jararaca","volume":"15","author":"Ferreira","year":"1963","journal-title":"Ci\u00eancias E Cult."},{"key":"10.1016\/j.peptides.2018.10.005_bib0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1476-5381.1965.tb02091.x","article-title":"A bradykinin-potentiating factor (Bpf) present in the venom of Bothrops jararaca","volume":"24","author":"Ferreira","year":"1965","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.peptides.2018.10.005_bib0035","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1021\/bi00815a005","article-title":"Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom","volume":"9","author":"Ferreira","year":"1970","journal-title":"Biochemistry"},{"key":"10.1016\/j.peptides.2018.10.005_bib0040","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/BF01930447","article-title":"Inhibition of angiotensin-coverting enzyme by analogs of peptides from Bothrops jararaca venom","volume":"8","author":"Cushman","year":"1973","journal-title":"Experientia"},{"key":"10.1016\/j.peptides.2018.10.005_bib0045","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1021\/bi00644a014","article-title":"Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids","volume":"25","author":"Cushman","year":"1977","journal-title":"Biochemistry"},{"key":"10.1016\/j.peptides.2018.10.005_bib0050","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1124\/jpet.107.120873","article-title":"Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? New insights from proline-rich peptides of Bothrops jararaca","volume":"322","author":"Ianzer","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.peptides.2018.10.005_bib0055","doi-asserted-by":"crossref","first-page":"20022","DOI":"10.1074\/jbc.M109.021089","article-title":"Argininosuccinate synthetase is a functional target for a snake venom anti-hypertensive peptide: role in arginine and nitric oxide production","volume":"284","author":"Guerreiro","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2018.10.005_bib0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/cyto.a.20963","article-title":"The snake venom peptide Bj-PRO-7a is a M1 muscarinic acetylcholine receptor agonist","volume":"79","author":"Negraes","year":"2011","journal-title":"Cytometry A"},{"key":"10.1016\/j.peptides.2018.10.005_bib0065","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.bcp.2010.12.016","article-title":"Bj-PRO-5a, a natural angiotensin-converting enzyme inhibitor, promotes vasodilatation mediated by both bradykinin B\u2082and M1 muscarinic acetylcholine receptors","volume":"81","author":"Morais","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.peptides.2018.10.005_bib0070","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00726-013-1630-x","article-title":"Insights into cardiovascular effects of proline-rich oligopeptide (Bj-PRO-10c) revealed by structure-activity analyses: dissociation of antihypertensive and bradycardic effects","volume":"46","author":"Paschoal","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.peptides.2018.10.005_bib0075","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1242\/jeb.00361","article-title":"The caveolar nitric oxide synthase\/arginine regeneration system for NO production in endothelial cells","volume":"206","author":"Solomonson","year":"2003","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.peptides.2018.10.005_bib0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/1753944711427318","article-title":"BPP-5a produces a potent and long-lasting NO-dependent antihypertensive effect","volume":"5","author":"Ianzer","year":"2011","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.peptides.2018.10.005_bib0085","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.HYP.9.6.611","article-title":"Overall hemodynamic pattern in coarctation of the abdominal aorta in conscious rats","volume":"9","author":"Stanek","year":"1987","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2018.10.005_bib0090","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/01.hjh.0000358834.18311.fc","article-title":"Endothelial dysfunction in spontaneously hypertensive rats: focus on methodological aspects","volume":"27","author":"Bernatova","year":"2009","journal-title":"J. Hypertens."},{"key":"10.1016\/j.peptides.2018.10.005_bib0095","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.HYP.31.2.643","article-title":"Alterations of nitric oxide synthase expression with aging and hypertension in rats","volume":"31","author":"Chou","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2018.10.005_bib0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00004872-198706000-00019","article-title":"Reactivity of aorta and mesenteric microvessels to drugs in spontaneously hypertensive rats: role of the endothelium","volume":"5","author":"Carvalho","year":"1987","journal-title":"J. Hypertens."},{"key":"10.1016\/j.peptides.2018.10.005_bib0105","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00004872-199816050-00008","article-title":"Alterations to the nitric oxide pathway in the spontaneously hypertensive rat","volume":"16","author":"Nava","year":"1998","journal-title":"J. Hypertens."},{"key":"10.1016\/j.peptides.2018.10.005_bib0110","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.peptides.2016.09.001","article-title":"Bradykinin-induced vasodilatation: role of age, ACE1-inhibitory peptide, mas-and bradykinin receptors","volume":"85","author":"Siltari","year":"2016","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2018.10.005_bib0115","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1152\/ajpcell.1990.258.3.C399","article-title":"Cyclic GMP-dependent protein kinase mediates the reduction of Ca2+ by cyclic AMP in vascular smooth muscle cells","author":"Lincoln","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.peptides.2018.10.005_bib0120","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/FJC.0b013e31816d5f2f","article-title":"Muscarinic receptor knockout mice confirm involvement of M3 receptor in endothelium-dependent vasodilatation in mouse arteries","volume":"51","author":"B\u00e9ny","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.peptides.2018.10.005_bib0125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1476-5381.1994.tb13104.x","article-title":"Mediation by M3-muscarinic receptors of both endothelium-dependent contraction and relaxation to acetylcholine in the aorta of the spontaneously hypertensive rat","volume":"112","author":"Boulanger","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.peptides.2018.10.005_bib0130","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.2042-7158.1991.tb03555.x","article-title":"M3-muscarinic receptor mediates prejunctional inhibition of noradrenaline release and the relaxation in cat femoral artery","volume":"43","author":"Fern\u00e1ndes","year":"1991","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.peptides.2018.10.005_bib0135","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1167\/iovs.09-3600","article-title":"Cholinergic dilation of ophthalmic arteries is abolished in M3, but retained in M5 muscarinic acetylcholine receptor knockout mice","volume":"3","author":"Gericke","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.peptides.2018.10.005_bib0140","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/01.ATV.0000130661.82773.ca","article-title":"Muscarinic (M) receptors in coronary circulation: gene-targeted mice define the role of M2 and M3 receptors in response to acetylcholine","volume":"24","author":"Lamping","year":"2004","journal-title":"Arter. Thromb Vasc. Biol."},{"key":"10.1016\/j.peptides.2018.10.005_bib0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1476-5381.1996.tb15688.x","article-title":"M1and M3 muscarinic receptors in human pulmonary arteries","author":"Norel","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.peptides.2018.10.005_bib0150","doi-asserted-by":"crossref","first-page":"14096","DOI":"10.1073\/pnas.251542998","article-title":"Cholinergic dilation of cerebral blood vessels is abolished in M 5 muscarinic acetylcholine receptor knockout mice","author":"Yamada","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2018.10.005_bib0155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0022-3565(25)22363-1","article-title":"Pharmacological characterization of muscarinic receptors mediating acetylcholine-induced contraction and relaxation in rabbit intrapulmonary arteries","volume":"270","author":"Altiere","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.peptides.2018.10.005_bib0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0014-2999(88)90083-0","article-title":"Muscarinic receptor subtypes mediating vasodilation in the pulmonary artery","volume":"158","author":"McCormack","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2018.10.005_bib0165","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.RES.82.2.186","article-title":"Coronary hemodynamics in endothelial NO synthase knockout mice","volume":"82","author":"Godecke","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.peptides.2018.10.005_bib0170","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCRESAHA.107.164798","article-title":"Reduced phospholamban phosphorylation is associated with impaired relaxation in left ventricular myocytes from neuronal NO synthase \u2013 deficient mice","volume":"102","author":"Zhang","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.peptides.2018.10.005_bib0175","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCULATIONAHA.108.846402","article-title":"Neuronal nitric oxide synthase protects against myocardial infarction-induced ventricular arrhythmia and mortality in mice","volume":"120","author":"Burger","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2018.10.005_bib0180","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.jacc.2011.12.046","article-title":"Cardioprotective Effect of Beta-3 Adrenergic Receptor Agonism: Role of Neuronal Nitric Oxide Synthase: Beta3-AR prevents cardiac dysfunction through nNOS","volume":"59","author":"Niu","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.peptides.2018.10.005_bib0185","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1113\/jphysiol.2013.270306","article-title":"Molecular mechanisms of neuronal nitric oxide synthase in cardiac function and pathophysiology","volume":"592","author":"Zhang","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.peptides.2018.10.005_bib0190","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1161\/01.RES.0000064585.95749.6D","article-title":"UltraRapid communication cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling","volume":"92","author":"Sears","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.peptides.2018.10.005_bib0195","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.bbabio.2009.02.007","article-title":"Nitrite exerts potent negative inotropy in the isolated heart via eNOS-independent nitric oxide generation and cGMP\u2013PKG pathway activation","volume":"1787","author":"Pellegrino","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.peptides.2018.10.005_bib0200","first-page":"1","article-title":"Neuronal nitric oxide synthase in hypertension \u2013 an update","author":"Zhang","year":"2016","journal-title":"Clin. Hypertens."},{"key":"10.1016\/j.peptides.2018.10.005_bib0205","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.freeradbiomed.2010.04.004","article-title":"Subcellular and cellular locations of nitric-oxide synthase isoforms as determinants of health and disease","volume":"49","author":"Villanueva","year":"2010","journal-title":"Free Radic. Biomol. Med."},{"key":"10.1016\/j.peptides.2018.10.005_bib0210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00395-010-0084-5","article-title":"PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation","volume":"105","author":"Lee","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.peptides.2018.10.005_bib0215","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.peptides.2018.10.005_bib0220","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pharmthera.2009.02.009","article-title":"Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics","volume":"122","author":"Tsai","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.peptides.2018.10.005_bib0225","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1073\/pnas.88.4.1197","article-title":"Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes","volume":"88","author":"M\u00e9ry","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2018.10.005_bib0230","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0005-2744(80)90105-9","article-title":"RMI 12330A, an inhibitor of cyclic nucleotide phosphodiesterases and adenylate cyclase in kidney preparations","volume":"613","author":"Hunt","year":"1980","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.peptides.2018.10.005_bib0235","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0006-8993(99)01683-2","article-title":"The adenylate cyclase inhibitor MDL-12330A has a non-specific effect on glycine transport in M\u00fcller cells from the retina","volume":"838","author":"Gadea","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2018.10.005_bib0240","doi-asserted-by":"crossref","first-page":"28562","DOI":"10.1074\/jbc.M003147200","article-title":"Ca21 entry mediated by store depletion, S-nitrosylation, and TRP3 channels. Comparison of coupling and function","volume":"275","author":"van Rossum","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2018.10.005_bib0245","doi-asserted-by":"crossref","first-page":"e77934","DOI":"10.1371\/journal.pone.0077934","article-title":"The adenylyl cyclase inhibitor MDL-12,330A potentiates insulin secretion via blockade of voltage-dependent K+ channels in pancreatic Beta cells","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2018.10.005_bib0250","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jmb.2006.07.045","article-title":"Molecular details of cAMP generation in mammalian cells: a tale of two systems","volume":"362","author":"Kamenetsky","year":"2006","journal-title":"J Mol Bio."},{"key":"10.1016\/j.peptides.2018.10.005_bib0255","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev.pa.36.040196.002333","article-title":"Complexity and diversity of mammalian adenylyl cyclases","volume":"36","author":"Sunahara","year":"1996","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.peptides.2018.10.005_bib0260","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0735-1097(85)80438-1","article-title":"Regional myocardial function is not affected by severe coronary depressurization provided coronary blood flow is maintained","volume":"5","author":"Smalling","year":"1985","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.peptides.2018.10.005_bib0265","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1093\/eurheartj\/ehv235","article-title":"Fundamentals in clinical coronary physiology: why coronary flow is more important than coronary pressure","volume":"36","author":"Van De Hoef","year":"2015","journal-title":"Eur. Heart J."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019697811830189X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019697811830189X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:57:24Z","timestamp":1775249844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019697811830189X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":53,"alternative-id":["S019697811830189X"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2018.10.005","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BJ-PRO-7A and BJ-PRO-10C induce vasodilatation and inotropic effects in normotensive and hypertensive rats: Role of nitric oxide and muscarinic receptors","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2018.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}